ELVN Exercise Disclosure
Kunkel Lori Anne · SEC Form 4 · Filed Nov 3, 2026
Exercise
Calculated transaction value
$0
Kunkel Lori Anne Director
ELVN
Enliven Therapeutics
ELVN
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
ELVN daily price context
Close on/before transaction
$44.25
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 7,300 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001536368-26-000008
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$137.78K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN | Exercise | Oct 30, 2026 | $133.59K |
| Enliven Therapeutics, Inc. ELVN | Exercise | Oct 30, 2026 | $0 |
| Enliven Therapeutics, Inc. ELVN Current | Exercise | Oct 30, 2026 | $0 |
| Enliven Therapeutics, Inc. ELVN | Exercise | Oct 30, 2026 | $4.19K |